E~ythrocyte Glycolipids. The bovine erythroeyte ganglioside (structure I, Table I ) with slow migrating properties on thin-layer chromatography was isolated and its structure was determined by methylation analysis, direct probe mass spectrometry of the methylated ganglioside and of the methylated nonasaeeharide liberated by endo-fl-galactosidase of Escherichiafreundii, and by sequential degradation with various exoglycosidases as described previously (9) . Eight glyeolipid analogues (structures II to IX) with branched and unbranched carbohydrate structures were prepared by sequential degradation of the ganglioside with various combinations of exoglyeosidases (9) . Anti-I cold agglutinins from patients Ma, Woj, Step, Gra, Ver, Ful, Phi, Da, Seh, Low, and Zg have been described previously (5, (10) (11) (12) .
Antigenic Analysis of the Glycolipids. The reaetivities of the glycolipids with the various anti-I sera were determined by radioimmunoassays as described previously (8, 13) . Briefly, glyeolipids complexed with cholesterol and lecithin as carrier lipids (proportions of cholesterol, lecithin and glycolipids were 2:2:1 by weight) were used as inhibitors of the binding of the anti-I sera to a radioiodinated I-or (I + i)-active glycoprotein. The results were expressed as the minimum concentration of glycolipids giving 50% inhibition of binding. Table I shows the inhibitory activities of lacto-N-iso-octaosyl ceramide and its analogues with the anti-I sera Ver, Ful, Phi, Da, Low, and Zg in addition to the previously tested antisera Ma, Woj, Step, Gra, and Sch. With the exception of anti-I Zg, all the antM sera were inhibited by structure III. The I activity of structure III was abolished after removal of the two terminal fl-galactosyl residues to give lacto-Niso-hexaosyl eeramide (structure VI).
Results
A comparison of the reactions of the anti-I sera with structures I to IX indicate that none of the 11 antibodies tested was identical in the antigenic determinants that it recognized. However, three main types of reactivity could be distinguished. Anti-I sera Ma and Woj represent the first type which requires the 1 --~ 4, 1 --~ 6 chain, although the branched structure is not essential, in agreement with previous observations (6, 9, 10) . Anti-I sera Step, Gra, Ver, and Ful represent the second type which requires predominantly the 1 ~ 4, 1 ~ 3 chain but, unlike the first type, the 1 ~ 6 branching structure is required for full expression of the I activity, except with anti-I Ver which reacts equally well with the branched and straight chain structures III and VIII, respectively. The third type of anti-I activity is represented by sera Da, Sch, Low, and Phi which require both the 1 ~ 4, 1 ~ 6 and 1 ~ 4, 1 --* 3 branches to be present in the intact state as in structure III. Substitution of the terminal fl-galactosyl residues of the two chains with a-galactose or sialic acid decreases but does not necessarily abolish the I activity as seen with structures I and II.
Discussion
From these and previous studies with purified lacto-N-iso-octaosyl ceramide, lacto-N-nor-hexaosyl ceramide and their analogues (7, 9) , crucial information has been obtained on the molecular basis of I and i specificities and certain generalizations can now be made: (a) nonreducing terminal fl-galactose is an important part of both the I and i antigenic determinants; (b) an intact straight chain oligosaccharide with a repeating Galfll ~ 4GIcNAcfll ~ 3 sequence expresses the majority of i and part of I antigenic determinants; (c) the antigenic determinants recognized by the majority of anti-I-antibodies are expressed on intact 1 ~ 4, 1 ~ 6, and/or 1 ---* 4, 1 --~ 3 branched structures. 
The present studies reveal three main types of I specificity at the same time as demonstrating the individuality in the fine specificity of each monoclonal anti-I antibody. The dramatic differences between anti-I and anti-i cold agglutinins of different individuals in their hemagglutinating activities with erythrocytes of various Ii phenotypes and in their precipitation reactions with various precursor-like glycoproteins are well known. These differences have been previously used to subclassify anti-I and anti-i antibodies into subtypes (10, 12) . However, classification based on reactions with complex reference materials such as glycoproteins and erythrocytes are difficult to interpret, because of the extreme heterogeneity of their oligosaccharide chains. In fact, the present studies with the purified glycolipids have revealed considerable differences between the reactivities of anti-1
Step and those of Sch and Low, although the three antibodies had been assigned to the same group (anti-I group 3) on the basis of their precipitation reactions with water soluble glycoproteins (10) . Furthermore, among the four anti-I antibodies which require the intact branched structure, as in structure III, are antibodies previously assigned to anti-I group 3 (Sch and Low), group 4 (Gra), and group 5 (Da) (10) .
The ability of several anti-I antibodies to react with their antigenic determinants in the presence of external substitutions (a-linked galactose or sialic acid) is an important consideration in the interpretation of the antigenicity of complex structures (or mixtures) and of the effects of digestion with/~-galactosidase (14) . Substances rich in the carbohydrate sequences found in structures II, III, IV, and V would lose much of their I activity after /~-galactosidase treatment. However, substances rich in structure I would retain their activities after such treatment.
Thus far the antigenic determinants recognized by 2 of the 16 anti-I and anti-i cold agglutinins (anti-I Zg and anti-i Galli) are unknown. The specificities of the others have been shown to involve one or other kind of type 2 precursor chain (15), i.e. 1 4, 1 ~ 3 and/or 6 sequences. It is interesting to speculate whether type 1 chains (15) with 1 ~ 3, 1 ~ 3 sequence are involved in the specificities of Zg and Galli. So far, the branched or straight chain analogues of the 1 ~ 4, 1 ~ 3 sequence have been described in the precursor chains of blood group ABH-active glycolipids (16) and erythrocyte gangliosides (7, 9, 17) , and among oligosaccharides isolated from human milk (18) . It would be predicted that these analogues also exist as precursor chains of secreted human blood group substances, for substantial I and i activities are found on ovarian cyst glycoproteins of persons who are nonsecretors (5, 10, 19) .
Summary
Blood group I activities of the purified glycosphingolipid lacto-N-iso-octaosyl ceramide Gal/~ 1 --) 4GlcNAc/~ 1 ",a 6 Gal~l -* 4GIcNAc~I --~ 3Gal/~l --+ 4GIcB ~ Cer 3 Gal~l --* 4GIcNAc/~I/~ and 8 of its analogues have been evaluated with 11 anti-I sera including 5 anti-I sera previously tested. All but one of the antisera were inhibited by the lacto-N-iso-octaosyl structure. Three types of 1-specificity could be distinguished although none of the anti-I sera was identical in its inhibition patterns with the nine glycosphingolipid analogues. The anti-I sera Ma and Woj represent the first type and require an intact Galfll ~ 4GIcNAcfll ~ 6 chain, the anti-I sera Step, Gra, Ver, and Ful represent the second type which requires Galfll --* 4GlcNAefll ---* 3 chain with branching, and the anti-I sera Phi, Da, Sch, and Low belong to the third type which requires both branches to be intact. Anti-I antibodies vary in their ability to react with their antigenic determinants in the presence of external substitutions with a-linked galactose or sialic acid.
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